Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 12, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 40
- −8 vs. Q1 2022
- Portfolio value
- $182.6M
- −$69.6M (−27.6%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Renovacor, Inc.75989E114 | *W EXP 99/99/999 | 75,000 | $5.00K | <0.1% | 00.0% | Unchanged | – |
| Medicus Sciences AcquisitionG5960S124 | *W EXP 02/12/202 | 33,333 | $8.00K | <0.1% | 00.0% | Unchanged | – |
| PNTPOINT Biopharma Global Inc. | COM | 25,578 | $174.0K | 0.1% | +25,578 | New | History |
| VRDNViridian Therapeutics, Inc. | COM | 20,660 | $239.0K | 0.1% | −29,340−58.7% | Reduced | History |
| CRISCuris Inc | COM NEW | 340,349 | $335.0K | 0.2% | −9,651−2.8% | Reduced | History |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $382.0K | 0.2% | 00.0% | Unchanged | – |
| RCORRenovacor, Inc. | COM | 199,490 | $405.0K | 0.2% | 00.0% | Unchanged | History |
| SNCEScience 37 Holdings, Inc. | COM | 279,775 | $562.0K | 0.3% | +58,393+26.4% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 15,000 | $589.0K | 0.3% | +15,000 | New | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 170,000 | $721.0K | 0.4% | +170,000 | New | History |
| LIANYLianBio | SPONSORED ADS | 450,000 | $972.0K | 0.5% | +125,000+38.5% | Added | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 401,268 | $995.0K | 0.5% | +401,268 | New | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 40,000 | $1.08M | 0.6% | −85,000−68.0% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 125,000 | $1.13M | 0.6% | +125,000 | New | History |
| NAUTNautilus Biotechnology, Inc. | COM | 466,607 | $1.25M | 0.7% | −92,412−16.5% | Reduced | History |
| ACLXArcellx, Inc. | COMMON STOCK | 75,000 | $1.36M | 0.7% | +75,000 | New | History |
| ACRSAclaris Therapeutics, Inc. | COM | 100,000 | $1.40M | 0.8% | 00.0% | Unchanged | History |
| VINCVincerx Pharma, Inc. | COM NEW | 1,374,098 | $1.81M | 1.0% | 00.0% | Unchanged | History |
| CNTXContext Therapeutics Inc. | COM | 883,654 | $1.87M | 1.0% | +106,044+13.6% | Added | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 70,000 | $1.97M | 1.1% | −137,500−66.3% | Reduced | History |
| ARYEARYA Sciences Acquisition Corp V | CLASS A ORD SHS | 352,500 | $3.43M | 1.9% | −350,000−49.8% | Reduced | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 250,466 | $3.45M | 1.9% | −49,534−16.5% | Reduced | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 1,372,244 | $4.05M | 2.2% | +100,000+7.9% | Added | History |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $4.15M | 2.3% | – | – | – |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $4.24M | 2.3% | – | – | – |
| RPTXRepare Therapeutics Inc. | COM | 321,200 | $4.49M | 2.5% | −147,705−31.5% | Reduced | History |
| Bellus Health Inc New07987C204 | COM NEW | 493,278 | $4.56M | 2.5% | −106,722−17.8% | Reduced | – |
| MORFMorphic Holding, Inc. | COM | 215,723 | $4.68M | 2.6% | −249,931−53.7% | Reduced | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 85,000 | $5.62M | 3.1% | −75,000−46.9% | Reduced | History |
| KRTXKaruna Therapeutics, Inc. | COM | 45,000 | $5.69M | 3.1% | +37,500+500.0% | Added | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 75,000 | $5.98M | 3.3% | +45,000+150.0% | Added | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 100,000 | $7.16M | 3.9% | +25,000+33.3% | Added | History |
| Nanostring Technologies Inc63009RAD1 | NOTE 2.625% 5/0 | – | $8.02M | 4.4% | – | – | – |
| LNTHLantheus Holdings, Inc. | Stock | 140,000 | $9.24M | 5.1% | +25,000+21.7% | Added | History |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $10.9M | 6.0% | – | – | – |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 125,087 | $11.6M | 6.4% | +5,087+4.2% | Added | History |
| NARIInari Medical, Inc. | Stock | 222,173 | $15.1M | 8.3% | +2,173+1.0% | Added | History |
| KDNYChinook Therapeutics, Inc. | COM | 937,568 | $16.4M | 9.0% | +92,413+10.9% | Added | History |
| KURAKura Oncology, Inc. | COM | 928,256 | $17.0M | 9.3% | +4,109+0.4% | Added | History |
| ESTAEstablishment Labs Holdings Inc. | COM | 359,956 | $19.6M | 10.7% | +185,456+106.3% | Added | History |
Options (13)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| LLYEli Lilly & Co | Stock | – | $9.73M |
| NVAXNovavax Inc | COM NEW | $4.63M | $4.37M |
| ESTAEstablishment Labs Holdings Inc. | COM | $8.16M | – |
| KRTXKaruna Therapeutics, Inc. | COM | $5.69M | – |
| LNTHLantheus Holdings, Inc. | Stock | $4.62M | – |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | – | $4.25M |
| CLDXCelldex Therapeutics, Inc. | COM NEW | – | $3.91M |
| LEGNLegend Biotech Corp | SPONSORED ADS | – | $2.75M |
| MRNAModerna, Inc. | Stock | – | $2.14M |
| FATEFate Therapeutics Inc | COM | – | $1.67M |
| IOVAIovance Biotherapeutics, Inc. | COM | – | $1.66M |
| CELUCelularity Inc | COM CL A | $624.0K | – |
| LNAILunai Bioworks Inc. | COM | $386.0K | – |
Sold out since Q1 2022 (14)
Positions held at the end of Q1 2022 that are gone from this filing.
| Security | Class | Shares in Q1 2022 | Value in Q1 2022 | % of portfolio in Q1 2022 | History |
|---|---|---|---|---|---|
| SWTXSpringWorks Therapeutics, Inc. | COM | 247,000 | $13.9M | 5.5% | History |
| PTGXProtagonist Therapeutics, Inc | COM | 300,000 | $7.10M | 2.8% | History |
| NSTGNS Wind Down Co., Inc. | COM | 171,592 | $5.96M | 2.4% | History |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 300,000 | $2.97M | 1.2% | History |
| Medicus Sciences AcquisitionG5960S108 | CL A SHS | 300,000 | $2.93M | 1.2% | – |
| TVTXTravere Therapeutics, Inc. | COM | 100,000 | $2.58M | 1.0% | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 70,000 | $2.45M | 1.0% | History |
| XENEXenon Pharmaceuticals Inc. | COM | 80,000 | $2.45M | 1.0% | History |
| GBTGlobal Blood Therapeutics, Inc. | COM | 70,000 | $2.42M | 1.0% | History |
| Bio Green Med Solution, Inc.23254L603 | COM | 400,000 | $1.22M | 0.5% | – |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 65,282 | $586.0K | 0.2% | History |
| CALACalithera Biosciences, Inc. | COM | 1,000,000 | $404.0K | 0.2% | History |
| HYPRHyperfine, Inc. | COM CL A | 76,162 | $270.0K | 0.1% | History |
| BPMCBlueprint Medicines Corp | COM | 1,988 | $127.0K | 0.1% | History |